Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€5.98

€5.98

5.100%
0.29
5.100%
€19.86

€19.86

 
23.04.24 / Stuttgart Stock Exchange WKN: A3DWPS / Symbol: KALA / Name: Kala Pharmaceuticals / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
€19.50
02.04.24
0.00%
buy
€13.96
01.04.24
1.10%
buy
€20.23
17.11.23
14.70%
buy
€21.91
11.08.23
-41.69%
buy
Your prediction

Kala Pharmaceuticals Inc. Stock

Kala Pharmaceuticals Inc. dominated the market today, gaining €0.29 (5.100%).
Currently there is a rather positive sentiment for Kala Pharmaceuticals Inc. with 4 Buy predictions and 0 Sell predictions.
Based on the current price of 5.98 € the target price of 19 € shows a potential of 217.73% for Kala Pharmaceuticals Inc. which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Kala Pharmaceuticals Inc. stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Kala Pharmaceuticals Inc. in the next few years

Pros
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Kala Pharmaceuticals Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Kala Pharmaceuticals Inc. 5.100% -10.535% -21.082% -58.738% -12.730% -98.188% -
Ardelyx Inc. 0.600% -5.482% -15.972% 32.578% 3.218% -12.905% -
Salarius Pharmaceuticals Inc. 4.250% -0.935% -18.462% -68.120% -23.604% -98.261% -99.994%
Brainstorm Cell 1.170% -0.896% -1.485% -81.710% 114.440% -80.717% -

Comments

Prediction Buy
Perf. (%) 0.00%
Target price 19.499
Change
Ends at 02.04.25

KALA BIO, Inc. (NASDAQ: KALA) had its price target lowered by analysts at HC Wainwright from $22.00 to $21.00. They now have a "buy" rating on the stock.
Ratings data for KALA provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 1.10%
Target price 13.959
Change
Ends at 01.04.25

KALA BIO, Inc. (NASDAQ: KALA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $15.00 price target on the stock.
Ratings data for KALA provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 14.70%
Target price 20.231
Change
Ends at 17.11.24

KALA BIO, Inc. (NASDAQ: KALA) had its price target lowered by analysts at HC Wainwright from $24.00 to $22.00. They now have a "buy" rating on the stock.
Ratings data for KALA provided by MarketBeat
Show more